soul trial oral semaglutide cardiovascular outcomes 2024 nejm results found to lower risk of heart failure events in people with type 2 diabetes Cardiovascular risk reduction with once-weekly
Pay in 4 interest-free payments of $7.10 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12


























